Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
No Phase 1 or Phase 2 trial has been conducted for PDA as a distinct compound
A 24-week clinical trial published in Obesity Research (2011) tested AOD-9604 against placebo for fat reduction and found no statistically significant difference between groups a result that has kept the compound classified primarily as a research-stage peptide rather than one with an established, reproducible metabolic effect
Reduces inflammation and pain while improving joint mobility
Quick Overview Retatrutide is a once-weekly peptide
Warner, D
US$ 20.36
US$ 21.36
US$ 26.00
US$ 23.31
![Darkness Energy (236/203) [Sword & Shield: Evolving Skies] ARC109-C](https://cdn.shopify.com/s/files/1/0617/9821/9946/files/19d9d666-29dd-59ae-9612-5368f37b6dec.jpg?v=1725660992)
